References
- 1. Sharip A, Kunz J. Understanding the Pathogenesis of Spondyloarthritis. Biomolecules. 2020;10(10):1461. DOI: 10.3390/biom10101461
- 2. Bansal P, Rich T. Dural ectasias in ankylosing spondylitis. Clin Rheumatol. 2021;40(1):421-2. DOI: 10.1007/s10067-020-05348-1
- 3. Voruganti A, Bowness P. New developments in our understanding of ankylosing spondylitis pathogenesis. Immunology. 2020;161(2):94-102. DOI: 10.1111/imm.13242
- 4. Xu Y, Jiang W, Zhang H. Association between C-reactive protein gene variant and treatment efficacy of etanercept in ankylosing spondylitis patients receiving hip arthroplasty. J Clin Lab Anal. 2020;34(8):e23343. DOI: 10.1002/jcla.23343
- 5. Paç Kısaarslan A, Şahin N, Özdemir Çiçek S, Gündüz Z, Poyrazoğlu H, Düşünsel R. Evaluation of familial Mediterranean fever patients concomitant with juvenile spondyloarthropathy. Mod Rheumatol. 2021;31(3):718-24. DOI: 10.1080/14397595.2020.1812809
- 6. He D, Wang R, Liang S, Liang D, Xu F, Zeng C, et al. Comparison of secondary IgA nephropathy in patients with ankylosing spondylitis and rheumatoid arthritis. Mod Rheumatol. 2020;30(4):648-56. DOI: 10.1080/14397595.2019.1651493
- 7. Böröcz K, Simon D, Erdő-Bonyár S, Kovács KT, Tuba É, Czirják L, et al. Relationship between natural and infection-induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA. Clin Exp Immunol. 2021;203(1):32-40. DOI: 10.1111/cei.13521
- 8. Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, et al. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Care Res. 2019;71(10):1285-99. DOI: 10.1002/acr.24025
- 9. van der Heijde D, Gensler LS, Deodhar A, Baraliakos X, Poddubnyy D, Kivitz A, et al. Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study. Ann Rheum Dis. 2020;79(5):595-604. DOI: 10.1136/annrheumdis-2020-216980
- 10. Poddubnyy D. Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis. Rheumatology. 2020;59(Suppl4):iv6-17. DOI: 10.1093/rheumatology/keaa250
- 11. Kucuksezer UC, Aktas Cetin E, Esen F, Tahrali I, Akdeniz N, Gelmez MY, et al. The Role of Natural Killer Cells in Autoimmune Diseases. Front Immunol. 2021;12:622306. DOI: 10.3389/fimmu.2021.622306
- 12. Nordin J, Pettersson M, Rosenberg LH, Mathioudaki A, Karlsson Å, Murén E, et al. Association of Protective HLA-A With HLA-B∗27 Positive Ankylosing Spondylitis. Front Genet. 2021;12:659042. DOI: 10.3389/fgene.2021.659042
- 13. Wu X, Wu J, Li X, Wei Q, Lv Q, Zhang P, et al. The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients. Front Med. 2021;7:568790. DOI: 10.3389/fmed.2020.568790
- 14. Kasapoğlu Aksoy M, Altan L, Görükmez O, Güner A, Ayar K. The relationship between CRP gene polymorphism (rs2794521, rs3091244), ASDAS-CRP and ASDAS-ESR in ankylosing spondylitis. Mod Rheumatol. 2020;30(4):715-20. DOI: 10.1080/14397595.2019.1639916
- 15. Liu G, Hao Y, Yang Q, Deng S. The Association of Fecal Microbiota in Ankylosing Spondylitis Cases with C-Reactive Protein and Erythrocyte Sedimentation Rate. Mediators Inflamm. 2020;2020:8884324. DOI: 10.1155/2020/8884324
- 16. Proft F, Schally J, Brandt HC, Brandt-Juergens J, Rüdiger Burmester G, Haibel H, et al. Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study. Ther Adv Musculoskelet Dis. 2022;14:1759720X221085951. DOI: 10.1177/1759720X221085951
- 17. Proft F, Muche B, Spiller L, Rios Rodriguez V, Rademacher J, Weber AK, et al. Performance of the Ankylosing Spondylitis Disease Activity Score based on a quick quantitative C-reactive protein assay in patients with axial spondyloarthritis. Joint Bone Spine. 2020;87(1):69-73. DOI: 10.1016/j.jbspin.2019.07.007
- 18. Cabibi D, Tarantino G, Barbaria F, Campione M, Craxì A, Di Marco V. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. Dig Liver Dis. 2010;42(8):585-92. DOI: 10.1016/j.dld.2009.12.006
- 19. Wan L, Zhu H, Gu Y, Liu H. Diagnostic value of trait antinuclear antibodies and multiple immunoglobulin production in autoimmune diseases. J Clin Lab Anal. 2018;32(4):e22361. DOI: 10.1002/jcla.22361
- 20. Zhang T, Yang F, Zuo K, Wang J, Cheng Z, Zhang J. HLA-B27 Negativity Is Associated With Renal Function Decline in Patients With Ankylosing Spondylitis and Secondary IgA Nephropathy. Front Med. 2020;7:89. DOI: 10.3389/fmed.2020.00089
- 21. Rosenbaum JT, Hamilton H, Weisman MH, Reveille JD, Winthrop KL, Choi D. The Effect of HLA-B27 on Susceptibility and Severity of COVID-19. J Rheumatol. 2021;48(4):621-2. DOI: 10.3899/jrheum.200939
- 22. Wang G, Kim TH, Li Z, Cortes A, Kim K, Bang SY, et al. MHC associations of ankylosing spondylitis in East Asians are complex and involve non-HLA-B27 HLA contributions. Arthritis Res Ther. 2020;22(1):74. DOI: 10.1186/s13075-020-02148-5